Navigation Links
Dyadic International Engages The Abraham Group as Strategic Advisor
Date:6/21/2010

JUPITER, Fla., June 21 /PRNewswire-FirstCall/ -- Dyadic International, Inc. (Pink Sheets: DYAI), a global biotechnology company whose cutting-edge C1 platform technology addresses the needs of the multi-billion dollar biofuels market by producing enzymes at industrial scale which efficiently convert biomass into ethanol and other forms of alternative energy, announced today that it has engaged the influential consulting firm, The Abraham Group, to provide strategic advice and transactional assistance to Dyadic, as its exclusive biofuels client, as it actively pursues licensing opportunities and other strategic collaborations throughout the world. The Abraham Group is led by former U.S. Energy Secretary Spencer Abraham, who will also serve as a senior advisor to Dyadic.

(Logo: http://photos.prnewswire.com/prnh/20091214/DYADICLOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20091214/DYADICLOGO )

Dyadic's Executive Director of Strategic Alliances, Anne Whitehead, stated, "We are very pleased that Secretary Abraham and his firm have selected Dyadic as its exclusive biofuels client. The Abraham Group will help Dyadic build upon its previous licensing successes and enhance its biofuels strategy by leading an international initiative to further communicate the advantages of Dyadic’s C1 platform technology and its R&D capabilities to major international energy groups that are committed to the efficient and rapid commercialization of cellulosic ethanol and other forms of sustainable energy."

Secretary Abraham stated, "The future of United States energy policy will be based on our country's ability to develop and implement many different types of technologies to meet our growing energy needs. We are excited to work with Dyadic whose technology has already been licensed and shown to be a key component in the process of developing and commercializing non-food biofuels and other applications worldwide."

Dyadic's President and CEO, Mark Emalfarb, added, "We are excited to have a firm of the caliber of The Abraham Group represent Dyadic. Secretary Abraham's commitment to Dyadic is a clear sign of the progress and innovations we are achieving in the area of bioenergy and lends further credibility to our company and its technologies. We expect The Abraham Group's expertise and relationships in the global energy sector will help accelerate the further development and monetization of our technologies through new licensees and other collaborations."

Dyadic believes that its proprietary and patented C1 platform technology can be used as a cost-effective method to develop and produce alternatives to oil and petroleum-based products for a variety of multi-billion dollar markets. The C1 platform technology is based on a genetically sequenced fungal microorganism that has been genomically annotated by Scripps Florida, a division of The Scripps Research Institute. As a result of more than a decade of continued research and development, the C1 platform can be readily programmed to develop and produce novel enzymes on a commercial scale at low cost under broad operating conditions. These unique enzymes provide increased flexibility in the processing of multiple forms of biomass by biorefineries into fermentable sugars which, in turn, can be converted into biofuels such as cellulosic ethanol and butanol as well as chemicals, polymers and plastics.

Dyadic has previously licensed its C1 platform technology in the area of biofuels on a non-exclusive basis to Spanish biofuels and energy producer Abengoa Bioenergy, as well as to Codexis, a biofuels partner of Royal Dutch Shell. Dyadic and these licensees are continuing to improve the C1 platform technology to make manufacturing processes more efficient in producing greater quantities of biofuels at lower costs.

About The Abraham Group

The Abraham Group is a Washington, D.C. based international strategic consulting firm that specializes in assisting clients seeking opportunities in the international energy sector. The firm's Chairman & CEO, Spencer Abraham, served as U.S. Secretary of Energy from 2001 to 2005 and as a U.S. Senator from 1995 to 2001. The firm's partners include Joseph McMonigle, who was former Chief of Staff at the U.S. Department of Energy and Vice Chairman of the International Energy Agency Board of Governors, and Majida Mourad, who served as Senior Advisor to the Secretary as a lead Department representative on international energy matters in the Middle East, Australia, and Russia as well as various European and Asian countries. Please visit The Abraham Group's website at www.abrahamgroupllc.com.

About Dyadic

Dyadic is a global biotechnology company that uses its patented and proprietary technologies for the discovery, development, manufacture and sale of enzyme products and solutions to address the needs of the bioenergy, biopharmaceutical and industrial enzyme markets. Please visit Dyadic's website at www.dyadic.com.

Cautionary Statement for Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.


'/>"/>
SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
2. Dyadic International Strengthens Management Team
3. Dyadic International Extends Collaboration With The Scripps Research Institute
4. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
5. Very Small Embryonic-Like Stem Cell Mobilization Data Presented at International Society for Stem Cell Research Annual Meeting
6. PRA International Opens Phase I Unit in Budapest
7. Hamilton Thorne to launch Staccato(TM) laser at International Society of Stem Cell Research Annual Meeting
8. PRA International Exhibits at European Hematology Association Congress
9. Prestigious International Champalimaud Vision Award to US Scientists
10. Yongye International Hosts Official NASDAQ Visit to Inner Mongolia
11. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today announced ... 2015. --> --> For ... of $29.3 million, or $0.34 loss per share, compared to a ... the same period in 2014. For the year ended December 31, ... $1.05 loss per share, as compared to a net loss of ...
(Date:2/11/2016)... NEW YORK , Feb. 11, 2016  Bioethics International, ... how medicines are researched, developed, marketed and made accessible to ... BMJ Open had named the publication of the ... for 2015. The publication is also featured as one of ... published in the last year that are most frequently read. ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... dedicated to delivering cutting-edge information focused on the development and manufacture of ... become a premier sponsor of the 2016 BioProcess International Awards – Recognizing ...
(Date:2/11/2016)... BioInformant announces the February 2016 release of its ... and Technologies – Market Size, Segments, Trends, and Projections ... The first and only market research firm ... more than a decade of historical information on all ... type. This powerful 175 page global strategic report contains ...
Breaking Biology Technology:
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... Potentials of that Rising Market Are you ... new analysis forecasts revenues for checkpoint inhibitors. Visiongain,s ... world market, submarket, product and national level. ... Instead discover what progress, opportunities and revenues those ...
(Date:2/2/2016)... , Feb. 2, 2016   Parabon NanoLabs ... the U.S. Army Research Office and the Defense ... and sensitivity of the company,s Snapshot Kinship ... Mission and, more generally, defense-related DNA forensics.  Although ... capabilities (predicting appearance and ancestry from DNA evidence), ...
Breaking Biology News(10 mins):